Skip to main content
Get the Weekly ESG Brief

Perrigo Company plc

PRGONYSETrackedMarket Data VerifiedHealth CarePharmaceuticals

Coverage
Coverage universe Identity published; no third-party ESG observation yet.
ESG profile reviewed
Last editorial update to this profile.
Quote
Last verified closeObservation time is shown beside the price.
Methodology
How we rateProvider ratings are shown separately, never blended.

Market overview

USD 15.91

Down−USD 0.26 (−1.61%) Day change

Last verified close · As of · USD · Market data via Massive Stock Widgets

The market is closed. This is the last verified closing quote, not an intraday price.

Open
USD 16.01
Previous close
USD 16.17
Day high
USD 16.06
Day low
USD 15.58
Volume
2,359,211
Market cap
USD 2,201,431,296
Price chart · 1 Year
Perrigo Company plc 1 Year price chartPerrigo Company plc, nyse:PRGO, 1 Year price chart in USD. Start USD 21.70, end USD 16.09, high USD 21.94, low USD 9.25, down.
Period1 YearFirst closeUSD 21.70Last closeUSD 16.09Maximum closeUSD 21.94Minimum closeUSD 9.25Period change−USD 5.61Period percentage change−25.85%Chart as ofOct 19, 2026, 1:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 21.75 USD 21.75 USD 21.26 USD 21.70 1,707,500
USD 21.46 USD 22.01 USD 21.14 USD 21.94 2,834,800
USD 13.50 USD 13.62 USD 13.38 USD 13.44 2,706,500
USD 13.26 USD 13.39 USD 13.00 USD 13.23 28,640,300
USD 14.83 USD 14.83 USD 14.41 USD 14.59 2,685,100
USD 15.05 USD 15.17 USD 14.68 USD 14.72 2,104,700
USD 14.58 USD 14.60 USD 14.28 USD 14.32 2,330,300
USD 14.61 USD 14.71 USD 14.15 USD 14.41 3,746,600
USD 9.71 USD 9.77 USD 9.25 USD 9.42 5,095,600
USD 9.61 USD 9.66 USD 9.23 USD 9.25 5,827,500
USD 9.32 USD 9.64 USD 9.25 USD 9.53 2,850,300
USD 11.35 USD 11.63 USD 11.22 USD 11.47 2,171,400
USD 11.54 USD 11.70 USD 11.38 USD 11.51 1,734,200
USD 11.11 USD 11.24 USD 10.83 USD 10.91 2,266,100
USD 11.14 USD 11.41 USD 11.02 USD 11.05 2,351,700
USD 11.19 USD 11.38 USD 10.59 USD 10.70 2,725,900
USD 10.50 USD 10.58 USD 10.21 USD 10.31 5,444,100
USD 11.09 USD 11.36 USD 10.50 USD 10.72 2,668,500
USD 10.31 USD 10.70 USD 10.31 USD 10.68 3,289,200
USD 12.96 USD 13.19 USD 12.80 USD 12.97 2,182,400
USD 14.52 USD 14.90 USD 14.32 USD 14.43 3,689,200
USD 13.75 USD 13.81 USD 13.27 USD 13.48 2,246,800
USD 14.18 USD 14.80 USD 14.12 USD 14.26 2,168,900
USD 16.59 USD 16.79 USD 16.03 USD 16.09 2,893,800

Company Profile & Business Model Overview

Perrigo Company plc (PRGO) is a global manufacturer and supplier of over-the-counter (OTC) self-care health and wellness products and active pharmaceutical ingredients, selling branded and private-label consumer healthcare products across retail and pharmacy channels. Headquartered in Ireland with significant U.S. operations, Perrigo is listed on the NYSE under ticker PRGO and reports annual results and regulatory filings as a large-cap healthcare products company.

Sustainability Strengths & Catalysts (Pros)

  • Extensive OTC and private-label portfolio reduces reliance on a single product line and supports resilient revenues, which can enable sustained investment in product safety, quality systems, and compliance.
  • Global manufacturing and supply-chain footprint gives Perrigo the ability to implement standardized quality-control and environmental management practices across sites, supporting operational sustainability improvements.
  • Public company reporting and annual filings (10-K) provide transparency on governance, risk management and business operations, enabling investors to assess ESG-related policies and performance.

Material Risks & Governance Concerns (Cons)

  • As a manufacturer of OTC pharmaceuticals and consumer health products, Perrigo faces product safety, regulatory compliance and supply-chain risks that can lead to recalls, fines or reputational impacts if quality controls fail.
  • Large-scale manufacturing and global supply chains expose Perrigo to environmental impacts (energy use, emissions, chemical waste) and social risks (labor standards at suppliers) that require ongoing mitigation and disclosure improvements.

Related ESG Peer Equities

Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.

Explore Health Care Peers →

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

Coverage PendingThird-Party ESG Coverage Under Review

Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Data integrity and methodology

MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.

FAQ

Frequently Asked Questions

Direct answers on sustainability scores, risk methodologies, and peer rankings.

What is Perrigo Company plc (PRGO)'s ESG rating and sustainability score?

Formal published scorecards from MSCI and Sustainalytics are under ongoing review for Perrigo Company plc (PRGO). The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Is Perrigo Company plc considered an ESG leader or laggard in Health Care?

Independent benchmark status for Perrigo Company plc is evaluated relative to Health Care peers once third-party coverage publishes official methodology scores.

What are the main ESG risks and controversies for Perrigo Company plc?

Key material risks for Perrigo Company plc include: As a manufacturer of OTC pharmaceuticals and consumer health products, Perrigo faces product safety, regulatory compliance and supply-chain risks that can lead to recalls, fines or reputational impacts if quality controls fail.; Large-scale manufacturing and global supply chains expose Perrigo to environmental impacts (energy use, emissions, chemical waste) and social risks (labor standards at suppliers) that require ongoing mitigation and disclosure improvements.. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.

How does The Impact Investor evaluate ESG stock profiles?

The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.